Author
Listed:
- Qifeng Han
(Duke University Medical Center
Duke University Medical Center)
- Julia A. Jones
(Duke University Medical Center
Duke University Medical Center)
- Nathan I. Nicely
(Duke University Medical Center
Duke University Medical Center)
- Rachel K. Reed
(Duke University Medical Center
Duke University Medical Center)
- Xiaoying Shen
(Duke University Medical Center
Duke University Medical Center)
- Katayoun Mansouri
(Duke University Medical Center
Duke University Medical Center)
- Mark Louder
(National Instiftute of Allergy and Infectious Diseases (NIAID), NIH)
- Ashley M. Trama
(Duke University Medical Center
Duke University Medical Center)
- S. Munir Alam
(Duke University Medical Center
Duke University Medical Center)
- Robert J. Edwards
(Duke University Medical Center
Duke University Medical Center)
- Mattia Bonsignori
(Duke University Medical Center
Duke University Medical Center)
- Georgia D. Tomaras
(Duke University Medical Center
Duke University Medical Center
Duke University Medical Center
Duke University Medical Center)
- Bette Korber
(Los Alamos National Laboratory)
- David C. Montefiori
(Duke University Medical Center
Duke University Medical Center)
- John R. Mascola
(National Instiftute of Allergy and Infectious Diseases (NIAID), NIH)
- Michael S. Seaman
(Israel Deaconess Medical Center)
- Barton F. Haynes
(Duke University Medical Center
Duke University Medical Center
Duke University Medical Center)
- Kevin O. Saunders
(Duke University Medical Center
Duke University Medical Center
Duke University Medical Center
Duke University Medical Center)
Abstract
The HIV-1 envelope (Env) is the target for neutralizing antibodies and exists on the surface of virions in open or closed conformations. Difficult-to-neutralize viruses (tier 2) express Env in a closed conformation antigenic for broadly neutralizing antibodies (bnAbs) but not for third variable region (V3) antibodies. Here we show that select V3 macaque antibodies elicited by Env vaccination can neutralize 26% of otherwise tier 2 HIV-1 isolates in standardized virus panels. The V3 antibodies only bound to Env in its open conformation. Thus, Envs on tier 2 viruses sample a state where the V3 loop is not in its closed conformation position. Envelope second variable region length, glycosylation sites and V3 amino acids were signatures of neutralization sensitivity. This study determined that open conformations of Env with V3 exposed are present on a subset of otherwise neutralization-resistant virions, therefore neutralization of tier 2 HIV-1 does not always indicate bnAb induction.
Suggested Citation
Qifeng Han & Julia A. Jones & Nathan I. Nicely & Rachel K. Reed & Xiaoying Shen & Katayoun Mansouri & Mark Louder & Ashley M. Trama & S. Munir Alam & Robert J. Edwards & Mattia Bonsignori & Georgia D., 2019.
"Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations,"
Nature Communications, Nature, vol. 10(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10899-2
DOI: 10.1038/s41467-019-10899-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10899-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.